Diagnosis and Management of Sore Throat in Children
Confirm Group A streptococcal pharyngitis with a rapid antigen detection test (RADT) or throat culture before prescribing antibiotics, and treat positive cases with penicillin V or amoxicillin for 10 days. 1
Who to Test
Do not test children with clear viral features (conjunctivitis, cough, hoarseness, coryza, discrete oral ulcers, or diarrhea), as these strongly indicate viral etiology and testing is unnecessary. 1
Test children who present with:
- Sudden onset sore throat with fever 1
- Tonsillopharyngeal erythema with or without exudates 1
- Tender anterior cervical lymphadenopathy 1
- Age 5-15 years (peak incidence) 1
- Winter or early spring presentation 1
- Known exposure to streptococcal pharyngitis 1
Generally avoid testing children under 3 years unless they have specific risk factors like an older sibling with confirmed infection, as Group A streptococcal pharyngitis is uncommon in this age group. 1
Diagnostic Testing
A positive RADT is diagnostic and requires no further testing—proceed directly to treatment. 1, 2
Perform backup throat culture in children and adolescents with negative RADT results, as the incidence of Group A streptococcal pharyngitis and risk of rheumatic fever are higher in this population compared to adults. 1 Backup culture is generally not necessary in adults due to lower disease incidence and complication risk. 1
Do not use antistreptococcal antibody titers for routine diagnosis of acute pharyngitis. 1
First-Line Antibiotic Treatment
For children without penicillin allergy:
- Penicillin V: 250 mg twice or three times daily for 10 days (children); 250 mg four times daily or 500 mg twice daily for 10 days (adolescents/adults) 1, 3
- Amoxicillin: 50 mg/kg once daily (maximum 1,000 mg) or 25 mg/kg twice daily for 10 days—preferred in younger children due to better taste and syrup availability 1, 3
These narrow-spectrum agents are recommended due to proven efficacy, safety, low cost, and minimal impact on antibiotic resistance. 1, 3
Treatment for Penicillin-Allergic Patients
For non-anaphylactic penicillin allergy:
- First-generation cephalosporins (cephalexin 20 mg/kg per dose twice daily, maximum 500 mg per dose; or cefadroxil 30 mg/kg once daily, maximum 1 g) for 10 days 2
- Avoid broad-spectrum cephalosporins (cefaclor, cefuroxime, cefixime, cefdinir, cefpodoxime) as they are more expensive and promote antibiotic resistance 1
- Up to 10% of penicillin-allergic patients are also allergic to cephalosporins 1
For anaphylactic penicillin allergy:
- Clindamycin: 7 mg/kg per dose three times daily (maximum 300 mg per dose) for 10 days—resistance rate approximately 1% in the United States 1, 2
- Clarithromycin: 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days 2
- Azithromycin: 12 mg/kg once daily (maximum 500 mg) for 5 days 1, 2
Critical caveat: Macrolide resistance (erythromycin, clarithromycin, azithromycin) ranges from 5-8% in most U.S. areas, with higher rates in some regions. 1, 2 Clarithromycin for 10 days may be more effective than azithromycin for 5 days. 1
Symptomatic Management
Use acetaminophen or ibuprofen for moderate to severe symptoms or high fever as adjunctive therapy. 1, 2
Never use aspirin in children due to Reye syndrome risk. 1, 2
Do not use corticosteroids routinely—while they may reduce pain duration by approximately 5 hours, the minimal benefit does not justify potential adverse effects given the self-limited nature of the illness and efficacy of standard analgesics. 1, 2
Common Pitfalls to Avoid
Avoid treating viral pharyngitis with antibiotics—most sore throats in children are viral, and antibiotics provide no benefit while increasing resistance and side effects. 1, 3
Do not perform routine post-treatment testing unless specific circumstances warrant it. 1
Do not test or treat asymptomatic household contacts of patients with confirmed Group A streptococcal pharyngitis. 1
Distinguish true recurrent infections from chronic carriage with viral infections—patients with repeatedly positive cultures may be chronic carriers experiencing viral pharyngitis episodes, not requiring antibiotics unless specific high-risk situations exist. 1, 2